Savigliano, Italy

Alessandra Ghigo

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Kither Biotech Srl. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alessandra Ghigo. Retrieved from https://idiyas.com/inventor/alessandra-ghigo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Alessandra Ghigo and PI3Kγ Inhibitor Peptide Research.

Introduction

Alessandra Ghigo is an inventor based in Savigliano, Italy. Her patent work includes a peptide-based approach to inhibiting PI3Kγ, a target investigated for treating respiratory system diseases. Ghigo is associated with Kither Biotech Srl and has 3 patents.

Latest Patents

Ghigo’s listed latest patent concerns a PI3Kγ inhibitor peptide for the treatment of respiratory system diseases. The invention describes a fusion peptide containing an amino acid sequence identified as SEQ ID No. 1, or a related homolog with at least 90% identity, that can inhibit the kinase-independent function of PI3Kγ. It also includes a peptide capable of penetrating a cell.

Career Highlights

Ghigo’s patent activity reflects research into peptide-based methods for targeting PI3Kγ in respiratory disease. Her work is associated with Kither Biotech Srl, a company focused on developing therapeutic innovations.

Collaborations

Ghigo’s listed coworker is Emilio Hirsch. Their shared professional context is connected to Kither Biotech Srl and its research and development activities.

Conclusion

Alessandra Ghigo’s patent portfolio highlights an approach using cell-penetrating fusion peptides to inhibit PI3Kγ and support the development of potential treatments for respiratory system diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…